all report title image

CHRONIC SPONTANEOUS URTICARIA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Chronic Spontaneous Urticaria Market, By Drug Class (Monoclonal antibodies (Xolair, Dupixent), Antihistamines, and Phase 3 drugs (Ligelizumab, Remibrutinib)), By Type (Branded and Generic), By Form (Injectable, Tablets, Capsules, and Syrup), By Route of Administration (Oral and Subcutaneous), By Age (Pediatric, Adult, and Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In: 31 Mar, 2026
  • Code: CMI9407
  • Page number: 168
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026 - 2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Chronic Spontaneous Urticaria Market, By Drug Class
      • Global Chronic Spontaneous Urticaria Market, By Type
      • Global Chronic Spontaneous Urticaria Market, By Form
      • Global Chronic Spontaneous Urticaria Market, By Route of Administration
      • Global Chronic Spontaneous Urticaria Market, By Age
      • Global Chronic Spontaneous Urticaria Market, By Distribution Channel
      • Global Chronic Spontaneous Urticaria Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Chronic Spontaneous Urticaria Market, By Drug Class, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Monoclonal antibodies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
        • Xoair
        • Dupixent
    • Antlihistamines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Phase 3 drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
        • Ligelizumab
        • Remibrutinib
  5. Global Chronic Spontaneous Urticaria Market, By Type, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Branded
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Generic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  6. Global Chronic Spontaneous Urticaria Market, By Form, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Tablets
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Capsules
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Syrup
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  7. Global Chronic Spontaneous Urticaria Market, By Route of Administration, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Subcutaneous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  8. Global Chronic Spontaneous Urticaria Market, By Age, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Adult
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Geriatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  9. Global Chronic Spontaneous Urticaria Market, By Distribution Channel, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  10. Global Chronic Spontaneous Urticaria Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Age, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  11. Competitive Landscape

    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi S.A
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Regeneron Pharmaceuticals Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Genentech Inc (Roche Group)
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck & Co Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson Services Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AstraZeneca plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AbbVie Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amgen Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • UCB S.A
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  12. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  13. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Chronic Spontaneous Urticaria Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.